Market closed
Zynex/$ZYXI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zynex
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Ticker
$ZYXI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,000
Website
Zynex Metrics
BasicAdvanced
$69M
24.00
$0.09
0.81
-
Price and volume
Market cap
$69M
Beta
0.81
52-week high
$12.84
52-week low
$2.10
Average daily volume
409K
Financial strength
Current ratio
4.458
Quick ratio
3.419
Long term debt to equity
194.654
Total debt to equity
206.744
Dividend payout ratio (TTM)
0.30%
Interest coverage (TTM)
2.51%
Management effectiveness
Return on assets (TTM)
2.89%
Return on equity (TTM)
7.32%
Valuation
Price to earnings (TTM)
24
Price to revenue (TTM)
0.359
Price to book
1.93
Price to tangible book (TTM)
8.54
Price to free cash flow (TTM)
5.682
Growth
Revenue change (TTM)
4.36%
Earnings per share change (TTM)
-66.67%
3-year revenue growth (CAGR)
13.86%
3-year earnings per share growth (CAGR)
-41.08%
What the Analysts think about Zynex
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zynex stock.
Zynex Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zynex Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zynex News
AllArticlesVideos
May 19, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ZYXI
Accesswire·3 hours ago
Levi & Korsinsky Reminds Zynex, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXI
Accesswire·5 hours ago
Faruqi & Faruqi Reminds Zynex Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXI
GlobeNewsWire·5 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Zynex stock?
Zynex (ZYXI) has a market cap of $69M as of April 06, 2025.
What is the P/E ratio for Zynex stock?
The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 24 as of April 06, 2025.
Does Zynex stock pay dividends?
No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Zynex dividend payment date?
Zynex (ZYXI) stock does not pay dividends to its shareholders.
What is the beta indicator for Zynex?
Zynex (ZYXI) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.